Skip to main content
. 2021 Jan 1;26(3):443–449. doi: 10.1007/s10147-020-01844-1

Table 4.

Clinical annotation for simulated case 2

Core hospital Recommended therapy Considered therapy
A Everolimus + exemestane
B
C Trastuzumab deruxtecan
D Everolimus + exemestane, trastuzumab deruxtecan
E Trastuzumab deruxtecan
F Everolimus + exemestane
G
H Alpelisib Afatinib
I Alpelisib, niratinib
J Everolimus + exemestane
K PI3K inhibitor

not recommended/considered therapies